| Literature DB >> 30304813 |
Diana Constantinescu-Aruxandei1, Rodica Mihaela Frîncu2, Luiza Capră3, Florin Oancea4.
Abstract
Selenium is essential for humans and the deficit of Se requires supplementation. In addition to traditional forms such as Se salts, amino acids, or selenium-enriched yeast supplements, next-generation selenium supplements, with lower risk for excess supplementation, are emerging. These are based on selenium forms with lower toxicity, higher bioavailability, and controlled release, such as zerovalent selenium nanoparticles (SeNPs) and selenized polysaccharides (SPs). This article aims to focus on the existing analytical systems for the next-generation Se dietary supplement, providing, at the same time, an overview of the analytical methods available for the traditional forms. The next-generation dietary supplements are evaluated in comparison with the conventional/traditional ones, as well as the analysis and speciation methods that are suitable to reveal which Se forms and species are present in a dietary supplement. Knowledge gaps and further research potential in this field are highlighted. The review indicates that the methods of analysis of next-generation selenium supplements should include a step related to chemical species separation. Such a step would allow a proper characterization of the selenium forms/species, including molecular mass/dimension, and substantiates the marketing claims related to the main advantages of these new selenium ingredients.Entities:
Keywords: analysis; next-generation supplements; selenium; selenium nanoparticles; selenium polysaccharides; speciation; zerovalent selenium
Mesh:
Substances:
Year: 2018 PMID: 30304813 PMCID: PMC6213372 DOI: 10.3390/nu10101466
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Physiological window of selenium supplementation. Intakes lower than recommended dietary allowance (RDA) determine diseases related to selenium deficiency. Intakes higher than 200% could lead to disorders related to excess selenium. The U-shape relationship between selenium and disease status limits selenium supplementation to subjects with lower-than-optimal selenium status. The next-generation selenium supplements, due to reduced toxicity and controlled release, should present a lower risk of supplementation on subjects with (near) Se optimal status. Data were obtained from References [5,23,43,44,45,46,47].
Figure 2Potential benefits of the next-generation dietary supplements based on nanoselenium and selenium polysaccharides. The new forms of selenium ingredients were proven, in several experimental models, to have lower toxicity and higher bioavailability. The biological activities of such putative slow, controlled-release selenium forms are not limited to the already known effects of selenium. Additional effects, such as in vitro inhibition of biofilm formation by the multi-antibiotic resistant pathogenic bacteria or stimulation of beneficial microbiome on chicken, were recently reported for these new forms of selenium. Data were obtained from References [14,33,37,41,74,75,76,77,78,79].
Next-generation Se species and their biological effects *.
| Next-Generation Ingredients | Methods of (Bio)-Synthesizing SeNPs | Experimental Model | Biological Effect | Reference |
|---|---|---|---|---|
| SeNPs, chemical synthesis | (Vitamin C + Oseltamivir) (Quercetin + CdSe + ZnS), (Glutathione + NaOH) | (H1N1 influenza virus; MDCK cells), ( | Antimicrobial activity | [ |
| (L-cysteine or Ascorbic acid), (SDS + sodium sulfate × 5H2O or L-cysteine) | Moderate antimicrobial activity | [ | ||
| (Quercetin + CdSe + ZnS), (Se-substituted hydroxyapatite NPs) | (BGC-823 cells), (human HCCLM9 cells injected in Balb/c nude mice) | Anticancer effects | [ | |
| Berberine-loaded Se-coated nanostructured lipid carriers | Diabetic Sprague/Dawley rats | Enhanced hypoglycemic effect | [ | |
| (sodium alginate + reduced glutathione) | Male Sprague/Dawley (SD) rats | Protection against diabetic nephropathy | [ | |
| Ascorbic acid + dextrin | Wistar rats | Anti-inflammatory effect in arthritis | [ | |
| SeNPs, biogenic synthesis | Antimicrobial activity | [ | ||
|
| (DPPH assay; Phosphomolybdenum method) | Antioxidant effects | [ | |
|
| BALB/c mice | Anticancer effects | [ | |
|
| (Swiss albino rats) | Wound healing | [ | |
| SeNPs, assisted biosynthesis | BSA + ascorbic acid-assisted biosynthesis | Antimicrobial activity | [ | |
| BSA + glutathione-assisted biosynthesis | Male Kunming mice | Antioxidant effects | [ | |
| (siRNA + vitamin C), (Polysaccharides extracted from | (HepG-2 cell line), (HepG-2, A549, Hela, MCF-7, and PC3 cell lines) | Anticancer effects | [ | |
| Polysaccharides from | Male ICR diabetic mice | Anti-diabetic activity | [ | |
| SeNPs, Commercial source | Not available | cashmere goats | Improved fetal growth and hair follicle development | [ |
| Not available | Boer goats | Enhanced semen and testicular GSH-Px activity, protection of the plasma membrane and mitochondria midpiece of spermatozoa | [ | |
| Selenized polysaccharides | Fruits of | SH-SY5Y neuroblastoma cells | Neuroprotective effects | [ |
| (Fruits of | (ABTS, DPPH, FRAP assays), (DPPH, hydroxyl radical scavenging, reducing power assays), (Kumming mice with tumor) | Antioxidant effects | [ | |
|
| Kunming mice | Anti-ageing effects | [ | |
| (Male ICR diabetic mice), (Male SD diabetic rats) | Antidiabetic effects | [ | ||
|
| Immature dendritic cells from ICR mice | Immunostimulant (dendritic cells maturation) | [ | |
| (HepG-2, A549, and Hela cell lines), (H22 hepatoma cell line, Female Kunming Mice) | Anti-tumor activity | [ |
* A549: adenocarcinomic human alveolar basal epithelial cells; ABTS: 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); BALB/c: albino mice used in research; BGC823: gastric cancer cell line; BSA: Bovine Serum Albumin; DPPH: 2,2-diphenyl-1-picrylhydrazyl; FRAP: Ferric ion reducing antioxidant power; H22: Murine hepatoma cell line; HCCLM9: hepatocellular carcinoma cell line; HeLa: cell line derived from cervical cancer cells; Hep G-2: human hepatocyte carcinoma cell; ICR: Institute of Cancer Research; MCF-7: human breast cancer cell line from Michigan Cancer Foundation; MDCK: Madin-Darby Canine Kidney cells; PC3: prostate cancer cell line; SD: Sprague-Dawley (rat strain); SeNPs: selenium nanoparticles; SDS: sodium dodecyl sulfate; SH-SY5Y: bone marrow neuroblast cell line; siRNA: small interfering ribonucleic acid.
Figure 3Next-generation Se supplements and their (potential) moderate epigenetic effects. In red are enzymes influenced by Se level. A low level of Se disturbs one-carbon metabolism and S-adenosyl methionine restoration, because betaine homocysteine methyltransferase (BMHT) needs higher levels of selenium for optimal activity. A high level of Se leads to inhibition of DNA methyltransferases (DNMTs) and to competition for methyl groups, needed to produce methylated selenium amino acids. Excess selenium influences histone deacetylation and further cross-talk with DNA methylation. The seleno-amino acids are converted via transamination to seleno-keto-α-acids, which inhibit histone deacetylase (HDACc). Zerovalent selenium and selenium polysaccharides slowly release active selenium species via an equilibrium reaction. The rate of such an equilibrium reaction depends on consumption of the reaction products. In tissues of subjects with a normal/optimal selenium status, the consumption of the reaction products is lower and the release of active selenium species over the optimal status is slower. At a deficit-to-optimal level of intake, the selenium species are rapidly used for the expression of the deficit amino acids and seleno-proteins, and the rate of release is higher. The slow and consumption-controlled release of the bioactive Se species should allow a more adapted response of supplementation to selenium status. Figure modified from Oancea et al. [186]. Data were obtained from References [31,37,186,187].
Figure 4Schematic representation of the analytical procedures for determining and characterizing selenium in dietary supplements. The analysis of the next-generation selenium dietary supplements based on nanoselenium or on Se polysaccharides must include a step related to chemical species separation. Such a step would allow a proper characterization of the molecular mass/dimension of Se-based ingredients and it is mandatory to substantiate the marketing claims related to the main advantages of these new Se ingredients—lower toxicity, enhanced bioactivity, and slow and controlled release.
Overview of selenium analysis and quantification methods.
| Method | Samples | Advantages | Disadvantages |
|---|---|---|---|
| Inductively coupled plasma mass spectrometry (ICP-MS; in some case a collision cell was used) | Human plasma [ | Can handle both simple and complex matrices; better detection limit than AAS and ICP-OES; small sample volume | Interference from plasma gas (Ar) and chlorides; high set-up and operational cost |
| Atomic fluorescence spectrophotometer (AFS)/hydride generation atomic fluorescence spectrometry (HG-AFS) | Soil samples [ | Relatively simple equipment, the ability to analyze many samples in a short time | |
| Graphite furnace atomic absorption spectroscopy (GF-AAS)/flame atomic absorption spectrometry | Selenium nanoparticles [ | High sensitivity, reduced analysis time | Matrix interference |
| Hydride generation atomic absorption spectrometry (HG-AAS) | Selenium nanoparticles [ | Minimum matrix interference | Interference of transition metals |
| Electrothermal atomic absorption spectrometry (ETAAS) | Cereals, milk, cheese, vegetables, fish, plasma, whole blood, and tissues [ | Sensitive, high accuracy | Matrix interference in organic samples |
| Conjugated techniques using high-performance liquid chromatography with hydride generation atomic absorption spectrometry (HPLC–HG-AAS) | Dietary supplements [ | Relatively simple | |
| Hydrophilic ion interaction chromatography (HILIC) with inductively coupled plasma mass spectrometric detection (ICP-MS) | Torula yeast [ | ||
| Ion-pairing reversed-phase liquid chromatography HPLC–ICP-MS | Fish, seafood [ | ||
| High-performance liquid chromatography with inductively coupled plasma mass spectrometry (HPLC–ICP-MS), HPLC–Orbitrap MS | Seafood [ | Speciation and identification of organic selenium compounds | Unknown peaks, lack of standards and reference materials |
| HPLC–ICP-MS and derivatization gas chromatography with atomic emission detection (GC–AED) | Dietary supplements [ | ||
| Ultra-performance liquid chromatography mass spectrometry (UPLC–MS/MS) | Selenomethionine in rat plasma [ | ||
| UV photochemical vapor generation (photo-CVG) to transform Se in its volatile species | Se (VI) [ | ||
| Multidimensional chromatography with dual ICP-MS and electrospray ionization ESI-MS detection | Se-rich yeast [ | May identify peaks that are missed by ICP-MS | Sensitive to the presence of salts |
| Size exclusion chromatography (SEC) | Mushrooms, Se-yeast [ | ||
| Optical emission spectrometry inductively coupled plasma (ICP-OES) | Higher detection limit than ICP-MS; matrix interference |